MORPHOSYS AG v. JANSSEN BIOTECH, INC.

C.A. No. 16-221-LPS.

358 F.Supp.3d 354 (2019)

MORPHOSYS AG, Plaintiff, v. JANSSEN BIOTECH, INC., Genmab US, Inc. and Genmab a/s, Defendants.

United States District Court, D. Delaware.

Signed January 25, 2019.

Editors Note
Applicable Law: 35 U.S.C. § 271
Cause: 35 U.S.C. § 271 Patent Infringement
Nature of Suit: 830 Patent
Source: PACER


Attorney(s) appearing for the Case

Kelly E. Farnan , Christine D. Haynes , RICHARDS, LAYTON & FINGER, P.A., Wilmington, DE, James F. Hurst , KIRKLAND & ELLIS LLP, Chicago, IL Patricia A. Carson , Christopher T. Jagoe , and Aaron D. Resetarits , KIRKLAND & ELLIS LLP, New York, NY Attorneys for Plaintiff.

Jack B. Blumenfeld and Brian P. Egan , MORRIS, NICHOLAS, ARSHT & TUNNELL LLP, Wilmington, DE, Michael A. Morin , David P. Frazier , and Emily K. Sauter , LATHAM & WATKINS LLP, Washington, DC, Roger J. Chin , LATHAM & WATKINS LLP, San Francisco, CA, Brenda L. Danek and Ann Marie Wahls , LATHAM & WATKINS LLP, Chicago, IL 60661, Michael R. Seringhaus , LATHAM & WATKINS LLP, Menlo Park, CA, Attorneys for Defendants.


MEMORANDUM OPINION

MorphoSys, Inc. ("MorphoSys" or "Plaintiff") sued Janssen Biotech, Inc., Genmab US, Inc., and Genmab A/S (together, "Janssen" or "Defendants") for infringement of three patents on antibodies that bind to the CD38 protein. (D.I. 205) Pending before the Court are summary...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases